Home Amines 87913-26-6
87913-26-6,MFCD02101627
Catalog No.:AA004FC5

87913-26-6 | Tricyclo[3.3.1.13,7]decan-2-amine,N-(4-bromophenyl)-

Pack Size
Purity
Availability
Price(USD)
Quantity
  
10mg
≥98%
in stock  
$46.00   $32.00
- +
25mg
≥98%
in stock  
$80.00   $56.00
- +
250mg
95%
in stock  
$524.00   $367.00
- +
1g
95%
in stock  
$841.00   $589.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA004FC5
Chemical Name:
Tricyclo[3.3.1.13,7]decan-2-amine,N-(4-bromophenyl)-
CAS Number:
87913-26-6
Molecular Formula:
C16H20BrN
Molecular Weight:
306.2407
MDL Number:
MFCD02101627
SMILES:
Brc1ccc(cc1)NC1C2CC3CC1CC(C2)C3
Properties
Properties
 
Form:
Solid  
MP:
106-108°C  
Storage:
2-8℃;  

Computed Properties
 
Complexity:
280  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
18  
Hydrogen Bond Acceptor Count:
1  
Hydrogen Bond Donor Count:
1  
Rotatable Bond Count:
2  
XLogP3:
5  

Literature

Title: [Effect of ladasten on antenatal and postnatal development].

Journal: Eksperimental'naia i klinicheskaia farmakologiia 20120101

Title: [Ladasten versus placebo effect self-evaluated by neurasthenia patients with different EEG alpha rhythm types].

Journal: Eksperimental'naia i klinicheskaia farmakologiia 20120101

Title: Time course of histone deacetylase 1 and acetylated H3 and H4 histones in the brain of rats treated with ladasten.

Journal: Bulletin of experimental biology and medicine 20110301

Title: [Ladasten in the management of non-motor symptoms of Parkinson's disease].

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20110101

Title: [Analysis of the binding capacity of the benzodiazepine site of gabaa receptor in mice C57BL/6 and BALB/C pretreated with anxiolytics].

Journal: Eksperimental'naia i klinicheskaia farmakologiia 20110101

Title: [Effect of antiasthenic drug ladasten on the level of cytokines and behavior in experimental model of anxious depression in C57BL/6 male mice].

Journal: Eksperimental'naia i klinicheskaia farmakologiia 20110101

Title: [Self-evaluation of single test doses and objective indices of ladasten vs. placebo efficacy in neurasthenic patients].

Journal: Eksperimental'naia i klinicheskaia farmakologiia 20110101

Title: Proteomic analysis and identification of ladasten target proteins in rat brain.

Journal: Bulletin of experimental biology and medicine 20101101

Title: [Neurochemical study of effects of the new anxiolytic drugs afobazol and ladasten on the synthesis and metabolism of monoamines and their metabolites in the brain structures of Wistar rat on the model of monoamine synthesis blockade induced by aromatic amino acid decarboxylase inhibitor NSD-1015].

Journal: Eksperimental'naia i klinicheskaia farmakologiia 20100301

Title: [Role of the brain dopaminergic and serotoninergic systems in psychopharmacological effects of ladasten and sydnocarb].

Journal: Eksperimental'naia i klinicheskaia farmakologiia 20100201

Title: [Treatment of asthenic disorders in patients with psychoautonomic syndrome: results of a multicenter study on efficacy and safety of ladasten].

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20100101

Title: [Prospects for using ladasten preparations in patients with irritable bowel syndrome].

Journal: Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology 20100101

Title: Changes in CREB (SER133) content and DNA-binding activity of transcriptional factors in rat brain cells against the background of ladasten exposure.

Journal: Bulletin of experimental biology and medicine 20090501

Title: [Ladasten, the new drug with psychostimulant and anxiolytic actions in treatment of neurasthenia (results of the comparative clinical study with placebo)].

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20090101

Title: [Effect of ladasten on the psychophysiological parameters of healthy volunteers].

Journal: Eksperimental'naia i klinicheskaia farmakologiia 20090101

Title: [Characteristics of ladasten effect in neurasthenia patients with various EEG parameters].

Journal: Eksperimental'naia i klinicheskaia farmakologiia 20080101

Title: The effects of ladasten on dopaminergic neurotransmission and hippocampal synaptic plasticity in rats.

Journal: Neuropharmacology 20071001

Title: [Cytosine demethylation in the tyrosine hydroxylase gene promoter in the hypothalamus cells of the rat brain under the action of an aminoadamantane derivative Ladasten].

Journal: Genetika 20060701

Title: [Thermoprotector properties of a combination of sydnocarb with ladasten].

Journal: Eksperimental'naia i klinicheskaia farmakologiia 20060101

Title: [Comparative study of the effect of Ladasten, Sydnocarb and their combination on physical work ability of laboratory animals].

Journal: Eksperimental'naia i klinicheskaia farmakologiia 20060101

Title: [Pilot clinical trial of ladasten].

Journal: Eksperimental'naia i klinicheskaia farmakologiia 20060101

Title: Psychotropic effects of sidnocarb and ladasten in inbred mice with different reaction to emotional stress.

Journal: Bulletin of experimental biology and medicine 20050301

Title: The effect of ladasten on gene expression in the rat brain.

Journal: Doklady. Biochemistry and biophysics 20050101

Title: [Studying the mechanisms of ladasten action].

Journal: Eksperimental'naia i klinicheskaia farmakologiia 20050101

Title: [Effect of ladasten on reproduction function in male rats].

Journal: Eksperimental'naia i klinicheskaia farmakologiia 20050101

Title: [The effect of ladasten on the activity of cAMP-dependent protein kinases and the phosphorylation of proteins in brain cells of rats].

Journal: Eksperimental'naia i klinicheskaia farmakologiia 20040101

Title: [The effect of bromantan on the sexual behavior and conception in rats].

Journal: Eksperimental'naia i klinicheskaia farmakologiia 20040101

Title: [Ladasten induces the expression of genes regulating dopamine biosynthesis in various structures of rat brain].

Journal: Eksperimental'naia i klinicheskaia farmakologiia 20040101

Title: Toxic effect of single treatment with bromantane on neurological status of experimental animals.

Journal: Bulletin of experimental biology and medicine 20020401

Title: [Correction of physical performance of mice with the derivatives of 3-oxypyridine and pyridine].

Journal: Aviakosmicheskaia i ekologicheskaia meditsina = Aerospace and environmental medicine 20020101

Title: Effects of bromantan on offspring maturation and development of reflexes.

Journal: Neurotoxicology and teratology 20010101

Title: [Complex evaluation of the effect of bromantane on animal behavior].

Journal: Eksperimental'naia i klinicheskaia farmakologiia 20010101

Title: [The characteristics of the neuropsychotropic activity of bromantane in laboratory animals].

Journal: Eksperimental'naia i klinicheskaia farmakologiia 19990101

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:87913-26-6 Molecular Formula|87913-26-6 MDL|87913-26-6 SMILES|87913-26-6 Tricyclo[3.3.1.13,7]decan-2-amine,N-(4-bromophenyl)-